BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 19927122)

  • 1. Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes.
    Jacques TS; Swales A; Brzozowski MJ; Henriquez NV; Linehan JM; Mirzadeh Z; O' Malley C; Naumann H; Alvarez-Buylla A; Brandner S
    EMBO J; 2010 Jan; 29(1):222-35. PubMed ID: 19927122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
    Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
    Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice.
    Friedmann-Morvinski D; Bushong EA; Ke E; Soda Y; Marumoto T; Singer O; Ellisman MH; Verma IM
    Science; 2012 Nov; 338(6110):1080-4. PubMed ID: 23087000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell of origin determines tumor phenotype in an oncogenic Ras/p53 knockout transgenic model of high-grade glioma.
    Ghazi SO; Stark M; Zhao Z; Mobley BC; Munden A; Hover L; Abel TW
    J Neuropathol Exp Neurol; 2012 Aug; 71(8):729-40. PubMed ID: 22805776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative expression analysis reveals lineage relationships between human and murine gliomas and a dominance of glial signatures during tumor propagation in vitro.
    Henriquez NV; Forshew T; Tatevossian R; Ellis M; Richard-Loendt A; Rogers H; Jacques TS; Reitboeck PG; Pearce K; Sheer D; Grundy RG; Brandner S
    Cancer Res; 2013 Sep; 73(18):5834-44. PubMed ID: 23887970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p18Ink4c and p53 Act as tumor suppressors in cyclin D1-driven primitive neuroectodermal tumor.
    Saab R; Rodriguez-Galindo C; Matmati K; Rehg JE; Baumer SH; Khoury JD; Billups C; Neale G; Helton KJ; Skapek SX
    Cancer Res; 2009 Jan; 69(2):440-8. PubMed ID: 19147556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma.
    Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; dePinho RA
    Cold Spring Harb Symp Quant Biol; 2008; 73():427-37. PubMed ID: 19150964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic Astrocyte Heterogeneity Influences Tumor Growth in Glioma Mouse Models.
    Irvin DM; McNeill RS; Bash RE; Miller CR
    Brain Pathol; 2017 Jan; 27(1):36-50. PubMed ID: 26762242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 and PTEN gene mutations in gemistocytic astrocytomas.
    Watanabe K; Peraud A; Gratas C; Wakai S; Kleihues P; Ohgaki H
    Acta Neuropathol; 1998 Jun; 95(6):559-64. PubMed ID: 9650746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain cancer stem-like cell genesis from p53-deficient mouse astrocytes by oncogenic Ras.
    Lee JS; Gil JE; Kim JH; Kim TK; Jin X; Oh SY; Sohn YW; Jeon HM; Park HJ; Park JW; Shin YJ; Chung YG; Lee JB; You S; Kim H
    Biochem Biophys Res Commun; 2008 Jan; 365(3):496-502. PubMed ID: 18021740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term culture and differentiation of human glioma stem cells ].
    Yang LY; Wang CY; Zheng JK; Wen JC; Li WY; Huang XP
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):141-4. PubMed ID: 16468664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocyte-specific expression of CDK4 is not sufficient for tumor formation, but cooperates with p53 heterozygosity to provide a growth advantage for astrocytes in vivo.
    Huang ZY; Baldwin RL; Hedrick NM; Gutmann DH
    Oncogene; 2002 Feb; 21(9):1325-34. PubMed ID: 11857076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult Lineage-Restricted CNS Progenitors Specify Distinct Glioblastoma Subtypes.
    Alcantara Llaguno SR; Wang Z; Sun D; Chen J; Xu J; Kim E; Hatanpaa KJ; Raisanen JM; Burns DK; Johnson JE; Parada LF
    Cancer Cell; 2015 Oct; 28(4):429-440. PubMed ID: 26461091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gliomagenesis arising from Pten- and Ink4a/Arf-deficient neural progenitor cells is mediated by the p53-Fbxw7/Cdc4 pathway, which controls c-Myc.
    Kim HS; Woolard K; Lai C; Bauer PO; Maric D; Song H; Li A; Kotliarova S; Zhang W; Fine HA
    Cancer Res; 2012 Nov; 72(22):6065-75. PubMed ID: 22986743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of molecular alterations in microdissected archival gliomas.
    Walker C; Joyce KA; Thompson-Hehir J; Davies MP; Gibbs FE; Halliwell N; Lloyd BH; Machell Y; Roebuck MM; Salisbury J; Sibson DR; Du Plessis D; Broome J; Rossi ML
    Acta Neuropathol; 2001 Apr; 101(4):321-33. PubMed ID: 11355303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanog-induced dedifferentiation of p53-deficient mouse astrocytes into brain cancer stem-like cells.
    Moon JH; Kwon S; Jun EK; Kim A; Whang KY; Kim H; Oh S; Yoon BS; You S
    Biochem Biophys Res Commun; 2011 Aug; 412(1):175-81. PubMed ID: 21810410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain tumor stem cells.
    Xie Z
    Neurochem Res; 2009 Dec; 34(12):2055-66. PubMed ID: 19856100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olig1/2-Expressing Intermediate Lineage Progenitors Are Predisposed to PTEN/p53-Loss-Induced Gliomagenesis and Harbor Specific Therapeutic Vulnerabilities.
    Verma R; Chen X; Xin D; Luo Z; Ogurek S; Xin M; Rao R; Berry K; Lu QR
    Cancer Res; 2023 Mar; 83(6):890-905. PubMed ID: 36634201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.
    Dai C; Celestino JC; Okada Y; Louis DN; Fuller GN; Holland EC
    Genes Dev; 2001 Aug; 15(15):1913-25. PubMed ID: 11485986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qki deficiency maintains stemness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation.
    Shingu T; Ho AL; Yuan L; Zhou X; Dai C; Zheng S; Wang Q; Zhong Y; Chang Q; Horner JW; Liebelt BD; Yao Y; Hu B; Chen Y; Fuller GN; Verhaak RG; Heimberger AB; Hu J
    Nat Genet; 2017 Jan; 49(1):75-86. PubMed ID: 27841882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.